Literature DB >> 31398412

Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids.

Sarah H Heil1, Heidi S Melbostad2, Catalina N Rey3.   

Abstract

Dramatic increases in the rate of opioid use disorder (OUD) during pregnancy have been paralleled by substantial increases in the number of neonates diagnosed with neonatal abstinence syndrome (NAS). Women with OUD have reliably reported high rates of unintended pregnancy and a number of studies also indicate they desire easier access to contraception. Recent statements from the Centers for Disease Control and Prevention and the American Academy of Pediatrics/American College of Obstetricians and Gynecologists have drawn increased attention to efforts to prevent unintended pregnancy and improve access to contraception among women with OUD. We briefly review a number of innovative clinical approaches in these areas, including efforts to integrate family planning services into substance use disorder (SUD) treatment and other settings that serve people with OUD and interventions that aim to make family planning a higher priority among women with OUD. Results suggest many of these approaches have led to increases in contraceptive use and may aid in efforts to reduce unintended pregnancy and improve access to contraception among women with OUD now and in the future.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraception; Family planning; Opioid; Opioid use; Opioid use disorder; Unintended pregnancy

Mesh:

Year:  2019        PMID: 31398412      PMCID: PMC6879827          DOI: 10.1016/j.ypmed.2019.105794

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  34 in total

1.  Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs.

Authors:  Lauren K MacAfee; Vanessa Dalton; Mishka Terplan
Journal:  J Addict Med       Date:  2019 May/Jun       Impact factor: 3.702

Review 2.  Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Authors:  Mishka Terplan; Dennis J Hand; Melissa Hutchinson; Elizabeth Salisbury-Afshar; Sarah H Heil
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

3.  A Public Health Response to Opioid Use in Pregnancy.

Authors:  Stephen W Patrick; Davida M Schiff
Journal:  Pediatrics       Date:  2017-02-20       Impact factor: 7.124

4.  Injectable Contraceptive Continuation among Female Exotic Dancers Seeking Mobile Reproductive Health Services.

Authors:  Caitlin E Martin; Jennifer J Han; Chris Serio-Chapman; Patrick Chaulk; Mishka Terplan
Journal:  J Health Care Poor Underserved       Date:  2014-08

5.  Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016.

Authors:  Carly E Milliren; Munish Gupta; Dionne A Graham; Patrice Melvin; Maria Jorina; Al Ozonoff
Journal:  Hosp Pediatr       Date:  2018-01

6.  Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.

Authors:  Stacey C Sigmon; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2005-12

7.  Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.

Authors:  Marjorie Meyer; Anna Benvenuto; Diantha Howard; Anne Johnston; Dawn Plante; Jerilyn Metayer; Todd Mandell
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

8.  Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: A randomized controlled trial.

Authors:  Rebecca L Schacht; Robert K Brooner; Van L King; Michael S Kidorf; Jessica M Peirce
Journal:  J Consult Clin Psychol       Date:  2017-04-17

9.  Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.

Authors:  Gabrielle K Welle-Strand; Svetlana Skurtveit; Hendreé E Jones; Helge Waal; Brittelise Bakstad; Lisa Bjarkø; Edle Ravndal
Journal:  Drug Alcohol Depend       Date:  2012-07-25       Impact factor: 4.492

10.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

View more
  5 in total

1.  Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.

Authors:  Nadia Abbass; Tani Malhotra; Brooke Bullington
Journal:  J Clin Ethics       Date:  2022

2.  Expanding Contraception Access for Women With Opioid-Use Disorder: A Qualitative Study of Opportunities and Challenges.

Authors:  Emily A Hurley; Alex Duello; Sarah Finocchario-Kessler; Kathy Goggin; Stephani Stancil; Rachel P Winograd; Melissa K Miller
Journal:  Am J Health Promot       Date:  2020-05-29

3.  Contraception Policies in U.S. Jails, Prisons, and Juvenile Detention Systems: A National Survey.

Authors:  Aneesha Cheedalla; Carolyn B Sufrin
Journal:  J Correct Health Care       Date:  2021-08-12

4.  Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.

Authors:  Joy D Scheidell; Janna Ataiants; Stephen E Lankenau
Journal:  Subst Use Misuse       Date:  2022-03-11       Impact factor: 2.362

5.  Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.

Authors:  Hendrée E Jones; Caitlin E Martin; Kimberly R Andringa; Rachel Middlesteadt Ellerson; Elisabeth Johnson; Essence Hairston; Kevin E O' Grady
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.